![David Sandoval](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Sandoval
Compliance Officer chez
MILESTONE PHARMACEUTICALS INC.
Fortune : 77 705 $ au 31/05/2026
Profil
David Sandoval currently serves as Chief Compliance Officer & General Counsel at Milestone Pharmaceuticals, Inc. since 2026.
Memberships include the New York State Bar Association and the New Jersey State Bar Association.
Former roles include Senior VP-Legal & Deputy General Counsel at MaxCyte, Inc. from 2023 to 2024, Chief Legal & Compliance Officer at Leadiant Biosciences, Inc. from 2010 to 2023, and Assistant General Counsel at Enzon Pharmaceuticals, Inc. from 2007 to 2010.
Education includes graduate studies at New York University School of Law and undergraduate studies at Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAXCYTE, INC. 0,06 % | 18/03/2025 | 64 219 ( 0,06 % ) | 77 705 $ | 31/05/2026 |
Postes actifs de David Sandoval
| Sociétés | Poste | Début |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Compliance Officer | 10/02/2026 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
New Jersey State Bar Association
 New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Anciens postes connus de David Sandoval
| Sociétés | Poste | Fin |
|---|---|---|
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Compliance Officer | 01/11/2023 |
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Corporate Officer/Principal | 01/01/2010 |
| MAXCYTE, INC. | Conseiller Juridique Général | - |
Formation de David Sandoval
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New Jersey State Bar Association
New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
